AngioDynamics Expands Indications for the NanoKnife System Across Europe, Strengthening Multi-Organ Tumor Ablation Platform

Stock Information for AngioDynamics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About AngioDynamics Inc.

AngioDynamics to Report Fiscal 2026 Third Quarter Results on April 2, 2026
AngioDynamics to Present at the Leerink Partners Global Healthcare Conference
AngioDynamics and The PERT Consortium® Launch Investigator-Led Research Fund to Advance Pulmonary Embolism Care
AngioDynamics to Convene Cardiovascular Leaders at Scientific Forum as Pipeline Continues to Advance
AngioDynamics Reports Fiscal Year 2026 Second Quarter Financial Results; Continued Double Digit Med Tech Growth Drives Increased Profitability
AngioDynamics to Report Fiscal 2026 Second Quarter Results on January 6, 2026
AngioDynamics to Present at the 44th Annual J.P. Morgan Healthcare Conference
AngioDynamics to Participate in the UBS Global Healthcare Conference

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.